Bayer AG Logo

Bayer AG

A life science firm providing pharmaceuticals, consumer health, and crop science solutions.

BAY | F

Overview

Corporate Details

ISIN(s):
DE0005752059 (+2 more)
LEI:
549300J4U55H3WP1XT59
Country:
Germany
Address:
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bayer AG is a global life science company with core competencies in healthcare and agriculture. Guided by its mission, "Health for all, Hunger for none," the company develops and commercializes products and services designed to address fundamental human needs and global challenges. Its operations are organized into three divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, offering over-the-counter medications and supplements; and Crop Science, providing seeds, crop protection, and digital farming solutions. Bayer's portfolio includes numerous world-famous brands and aims to foster innovation in health and nutrition to support a growing and aging global population.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 12:09
Declaration of Voting Results & Voting Rights Announcements
English 12.6 KB
2025-08-06 00:00
Interim Report
Half-yearly financial report 2025
English 472.4 KB
2025-08-04 13:55
Major Shareholding Notification
English 86.6 KB
2025-07-31 23:15
Earnings Release
Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings g…
English 12.2 KB
2025-07-24 14:09
Major Shareholding Notification
English 83.7 KB
2025-07-22 11:51
Declaration of Voting Results & Voting Rights Announcements
English 86.3 KB
2025-07-04 07:38
Declaration of Voting Results & Voting Rights Announcements
English 86.4 KB
2025-06-26 15:30
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-25 12:35
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-23 13:01
Declaration of Voting Results & Voting Rights Announcements
English 80.3 KB
2025-06-12 12:54
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-05-22 09:04
Major Shareholding Notification
English 23.4 KB
2025-05-21 14:01
Major Shareholding Notification
English 18.5 KB
2025-05-19 09:00
Declaration of Voting Results & Voting Rights Announcements
English 23.4 KB
2025-05-17 07:59
Declaration of Voting Results & Voting Rights Announcements
English 18.5 KB

Automate Your Workflow. Get a real-time feed of all Bayer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bayer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bayer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France ALQGC
QuidelOrtho Corp Logo
Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.
United States of America QDEL
Quince Therapeutics, Inc. Logo
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
United States of America QNCX
Quoin Pharmaceuticals, Ltd. Logo
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
United States of America QNRX
Quratis Inc. Logo
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea 348080
Radiopharm Theranostics Ltd Logo
Developing first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer.
United States of America RADX
Rallybio Corp Logo
Develops therapies for severe and rare diseases in hematology and complement dysregulation.
United States of America RLYB
Rani Therapeutics Holdings, Inc. Logo
Develops a capsule to convert injectable biologics into oral pills for chronic diseases.
United States of America RANI
Rapport Therapeutics, Inc. Logo
Developing precision small molecule medicines for Central Nervous System (CNS) disorders.
United States of America RAPP
RAPT Therapeutics, Inc. Logo
Developing immune-targeting therapies for inflammatory and immunologic diseases.
United States of America RAPT

Talk to a Data Expert

Have a question? We'll get back to you promptly.